Source: BUSINESS WIRE

Press Release: BioAlliance Pharma : BioAlliance Pharma Announces the Launch of Sitavig® in the United States by Its Partner Innocutis

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), an innovative Company specialized in the development of drugs in orphan oncology diseases, today announced the launch of Sitavig® (acyclovir Lauriad®) in the United States by its commercial partner, Innocutis Holdings LLC, and the granting of a new U.S. Sitavig® patent by the United States Patent and Trademark Office. A few weeks after the execution of a licensing agreement between the two compani

Read full article »
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
1-25
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100



BioAlliance Pharma is a Private company. BioAlliance Pharma has a revenue of $10M, and 10 employees. BioAlliance Pharma has 1 followers on Owler.